Company profile
PolyPid Ltd.
NASDAQ:PYPDMedical/Dental Instruments
Clinical trials (5)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03558984 | phase3 | terminated | 2019-12-17 | 2022-10-24 | PolyPid Ltd. | D-PLEX 302: Efficacy and Safety of D-PLEX in the Prevention of Sternal Infection Post Cardiac Surgery |
| NCT03633123 | phase2 | completed | 2018-10-04 | 2019-09-06 | PolyPid Ltd. | D-PLEX 310: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection |
| NCT04233424 | phase3 | completed | 2020-06-24 | 2022-09-02 | PolyPid Ltd. | D-PLEX 311: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection |
| NCT04411199 | phase3 | completed | 2020-12-15 | 2025-04-14 | PolyPid Ltd. | D-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II) |
| NCT02731573 | phase1_2 | completed | 2016-10-12 | 2018-02-01 | PolyPid Ltd. | Safety and Efficacy of D-PLEX in the Prevention of Sternal Infection Post Cardiac Surgery. |
FDA applications (0)
No records yet.